Prospective cross-over study on the interaction between furosemide and sevelamer in hemodialysis patients.

Prospective cross-over study on the interaction between furosemide and sevelamer in hemodialysis patients. - furosemide/sevelamer interaction study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33060

Enrollment

Registered

2010-03-03

Start date

2011-06-03

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dialyse patienten terminal renal failure

Interventions

t= day 8-14: Furosemide in combination with sevelamer 3 x 800mg

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age 18-90 years end stage renal disease, hemodialysis since >=3 months diuresis> 100ml/d with furosemide furosemide dosage >=500mg a day patient can collect 24h urine

Exclusion criteria

Exclusion criteria: sevelamer is contraindicated already using sevelamer cardiovascular instability clinically overhydrated engaged in medication research within 1 month prior to inclusion

Design outcomes

Primary

Measure	Time frame
volume 24 hr urine Concentration furosemide urine.	—

Secondary

Measure	Time frame
x	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)